Home > Boards > Canadian > Cannabis >

Auxly Cannabis Group Inc. (CBWTF)

Add CBWTF Price Alert      Hide Sticky   Hide Intro
Moderator: Diogenes of Sinope, TheGreatGreenRush
Search This Board: 
Last Post: 10/22/2019 6:58:20 AM - Followers: 166 - Board type: Free - Posts Today: 2


Current Share Structure

Current O/S: 606,189,817 2/26/2019
Current Float: 461,717,092 2/26/2019

Auxly Signs Definitive Agreement With Curative Cannabis

VANCOUVER, British Columbia, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (the "Company") is pleased to announce that the Company has signed a definitive agreement (the “Transaction”) with 2368523 Ontario Limited (d/b/a) Curative Cannabis ("Curative"). The Company will acquire 46% of the common shares of Curative and enter into a long-term cannabis purchase and sale agreement to fund the construction and development costs of Curative’s cannabis cultivation facility in Chatham-Kent, Ontario (the “Facility”).

The Facility is designed as a purpose-built indoor facility for the production of ultra-premium cannabis product. With an initial footprint spanning approximately 30,000 square feet, the first phase of the Facility is expected to yield approximately 2,900 kg of cannabis per annum. Curative anticipates bringing a unique ultra-premium cannabis product to Canadian recreational cannabis consumers through its proprietary genetics database of over 90 stable, and highly sought-after, cannabis strains (the "Genetic Library"). The first phase of the Facility, being built to EU GMP standards, is currently under construction with an anticipated completion and Health Canada evidence package submission date of March 2019. Curative’s Facility rests on a 33-acre land parcel thereby providing ample room for Facility expansion. Curative has already received municipal approval for the expansion of the Facility for up to an additional 120,000 square feet of indoor cultivation space.

Pursuant to the Transaction, the Company has entered into a share purchase agreement with certain shareholders of Curative, whereby the Company has agreed to purchase 46% of the common shares of Curative from certain Curative shareholders, in exchange for the issuance of 5,056,026 common shares of the Company (the “Consideration Shares”). The Company will also enter into a long-term cannabis purchase and sale agreement with Curative, pursuant to which the Company will fund the construction and development costs of the Facility in exchange for the right to purchase 50% of the cannabis products and cannabis trim produced at the Facility at an offtake price equal to Curative’s direct cost of cultivation plus 10%.

Additionally, the Company shall be granted: (i) a right of first refusal over any future expansion of the Facility and/or the proposed construction of any new cannabis production facility by Curative and if the Company exercises such right of refusal it shall be entitled to receive a comparable offtake purchase arrangement as it received under the Transaction; and (ii) unfettered access and control to Curative’s Genetic Library which can be transferred (at the Company's discretion), used and cultivated by the Company’s properly licensed subsidiaries, affiliates or commercial partners.

Hugo Alves, President and Director of Auxly Cannabis Group commented: “Curative is a highly valued partner to Auxly, having been a part of the Auxly family since the inception of the Company. That being said, we could not be more pleased to have reached this stage of the project and to be signing a definitive agreement with Curative. Curative’s optimization of indoor cultivation combined with their unique genetics will provide a highly desirable product offering to the Canadian recreational cannabis markets and to the Auxly platform as a whole. We are pleased to be working with Dave, Scott and their team as they build out additional phases of this project and bring their product to market.


Auxly Congratulates Streaming Partner Lotus Ventures on Obtaining Cannabis Licences From Health Canada

VANCOUVER, British Columbia, March 11, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its streaming partner, Lotus Ventures Inc. (“Lotus”), has been granted a “standard cultivation” licence and a “sale for medical purposes” licence by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Lotus the ability to begin cultivation at its fully constructed 22,500 square-foot facility in Armstrong, British Columbia (the “Facility”).
Hugo Alves, President of Auxly said: “We want to congratulate Dale, Stephen, Scott, Carl, Monica and the rest of the Lotus team on obtaining their Cannabis Act licences! This is an important step for Auxly as we continue to diversify our supply chain, utilizing a network of subsidiaries and partners to provide reliable sources of diverse raw product. Lotus is a partner that we value deeply, being one of Auxly’s first streaming partners. We look forward to continuing to work closely with the team at Lotus during these exciting new phases of their business.”
Deal Terms with Lotus
Pursuant to the definitive agreement entered into on September 11, 2018 (the “Transaction”), Auxly advanced $4,000,000 to Lotus to partially fund the completion of the Facility, which was in addition to Auxly’s $1,000,000 subscription of units of Lotus completed in January 2018. After completion of the Transaction, Auxly owned 5,755,868 common shares of Lotus and 1,000,000 five-year share purchase warrants exercisable at a price of $0.70. Additionally, Auxly is entitled to purchase or otherwise direct the sale of 50% of the Facility’s total production, which is expected to be 2,000 kg of cannabis per annum. Auxly also retains a right of first refusal to purchase the remaining 50% of cultivation output from the Facility, as well as a right of first refusal to finance a prescribed portion of the first expansion to the Facility and all or a portion of any further expansions of the Facility.
Other Business
The Company also announces that it has settled CDN$441,000 of debt in consideration for the issuance of 450,000 common shares of the Company at a price of $0.98 per common share. The common shares issued pursuant to the shares for debt settlement will be subject to a statutory four month and one day hold period.

Auxly Announces Completion of Inverell S.A. Acquisition

The Transaction positions the Company as a leader in the global CBD economy with a highly efficient, low-cost source of cannabinoids for international distribution, including through the Company's strategic partnership with ICC International Cannabis Corporation Inc. (CSE: WRLD) which provides the Company with access to 16 markets through a network of 35,000 pharmacies. Importantly, the low cost, high purity CBD produced by Inverell gives the Company a long-term and stable supply of CBD to support the research, development and manufacturing of cannabis-derived products at Dosecann Inc., the Company's wholly-owned Licensed Processor facility located in Prince Edward Island, Canada.

Hugo Alves, President and Director of Auxly Cannabis Group, commented: “We are incredibly pleased with progress that Inverell has made on the cultivation of its 2019 crop of CBD-rich hemp and on the broader development of the business as a stand-alone entity in the Auxly platform. In a very short period, Inverell has exceeded its 2018 planting target of 150 hectares of hemp plants and has made significant strides forward on the development of its world-class extraction facility located in the Parque de las Ciencias. We continue to believe that the low cost and high volume access to CBD molecules, through our ownership in Inverell, positions Auxly to be a leader in the global value-added cannabinoid-based product markets.”

("Acquisition Agreement”) to acquire all of the outstanding securities of Dosecann Inc. (“Dosecann”).

Dosecann is a late-stage “Licensed Dealer” applicant pursuant to the Narcotic Control Regulations with a purpose-built 42,000 square foot facility located in Charlottetown, Prince Edward Island.   

Pursuant to the Acquisition Agreement, Cannabis Wheaton will acquire all of the outstanding securities of Dosecann (the “Dosecann Securities”) by way of a “three-cornered amalgamation” (the “Acquisition”). Upon the completion of the Acquisition, Dosecann will become a wholly-owned subsidiary of Cannabis Wheaton.

As consideration for the Dosecann Securities, the Company will pay the holders of the Dosecann Securities an aggregate of up to $38,000,000, payable in common shares of Cannabis Wheaton (the “Consideration Shares”), subject to the satisfaction of certain post-closing time and performance-based milestones. As part of the Acquisition, all outstanding convertible securities of Dosecann will either be converted into Dosecann common shares and exchanged for Consideration Shares on the closing of the Acquisition (the “Closing”), or will otherwise be exchanged for convertible securities of Cannabis Wheaton based on the exchange ratio used in the Acquisition. 

The Dosecann principals, who collectively hold approximately 66.96% of the outstanding common shares of Dosecann, have agreed to enter into lock-up agreements in favour of Cannabis Wheaton restricting their ability to transfer their Consideration Shares (the “Locked-up Securities”) until the date that is 18 months following the Closing, provided that: (i) one-half of the Locked-Up Securities shall cease to be subject to the lock-up on the date that is 6 months following the Closing; and (ii) the remaining Locked-Up Securities shall cease to be subject to the lock-up in equal tranches on the 12th and 18th month anniversaries of the Closing.

The Acquisition is subject to a number of conditions, including the receipt of all required shareholder and regulatory approvals and the satisfaction or waiver of all conditions of closing under the Acquisition Agreement. The Transaction is expected to close on or about April 30, 2018.  
About Cannabis Wheaton (TSX-V:CBW)

Cannabis Wheaton is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brandvalues, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation.

About Dosecann

Dosecann Inc. is a PEI-based Licensed Dealer applicant currently completing the buildout of a 42,000 square foot GMP compliant facility. Within the purpose-built facility, Dosecann intends to accommodate product development, extraction, formulation, filling and packaging. Dosecann is developing a suite of cannabis products across a variety of delivery methods for both the medical and adult use markets.


Auxly Announces Receipt of Cultivation and Processing Licences for Robinsons Cannabis Facility

VANCOUVER, British Columbia, April 08, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its wholly-owned subsidiary, Robinsons Cannabis Inc. (“Robinsons”), has been granted standard cultivation and processing licences by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Robinsons the ability to begin cultivation at its fully constructed 27,700 square-foot facility in Kentville, Nova Scotia, which was purpose-built to produce high-quality cannabis.

Led by experienced head grower Andrew Robinson, Robinsons is uniquely positioned to capture the attention of luxury cannabis consumers, with operations built on a devotion to uncompromising quality and a premium cannabis experience. Robinsons products have consistently ranked the highest in terms of cannabinoid content, terpene content and overall quality when independently tested against 5,000 products supplied by various growers licenced in accordance with Canadian cannabis regulations. 

“We are thrilled to have achieved this major milestone,” says Andrew Robinson. “Our goal is to produce the best cannabis we can, for cannabis connoisseurs like ourselves. The licences will allow us to start production and take steps toward delivering a consistent final product focused on taste, smell, and potency.”

Hugo Alves, President of Auxly said: “This is a big milestone for one of our key subsidiaries and member of the Auxly family. We know that Andrew and his team are going to produce some of the best cannabis flower available in Canada and we can’t wait to share it with Canadian consumers. Robinsons is all about an unwavering commitment to quality. We hope to show cannabis connoisseurs, who to date have been generally disappointed with the flower offerings in the market, that passionate artisans operating in the regulated industry can produce an incredible product that reflects their pride and craftsmanship.”

Auxly expects that Robinsons’ premier products will be available for sale in the fourth quarter of this year, subject to receipt of sales authorization from Health Canada. With a focus on quality, Robinsons plans to release a limited amount of product to the market of approximately 1,100kg per year. 

Investor Relations:
For more information about investing in Cannabis Wheaton, please visit: http://www.wheatonincome.com or contact our Investor Relations Team: 
Email: IR@wheatonincome.com

Stay Connected: 
Follow up on Twitter @WheatonIncome

Media Enquiries (only): 
For media enquiries or to set up an interview please contact:
Sarah Bain, VP External Affairs 
Email: sarah@cannabiswheaton.com 
Phone: 613.230.5869




Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CBWTF News: Microgrid Tech That Could Change Cannabis 05/07/2019 08:37:13 AM
CBWTF News: Cannabis Stocks to Know this Week- THC Therapeutics, Inc. (THCT) 04/29/2019 01:20:00 PM
#2788  Sticky Note Auxly Welcomes $123 Million Investment and R&D Partnership Diogenes of Sinope 07/25/19 06:38:22 AM
#2134  Sticky Note NEWS: Auxly Announces Completion of Inverell S.A. Acquisition europa7 01/09/19 11:43:40 AM
#2944   No one cares about Auxly open market shares, greendragon420 10/22/19 06:58:20 AM
#2943   The XLY.wt warrants are an incredible deal at Ace Ventures 10/22/19 04:33:41 AM
#2942   It looks like one of the biggest Ace Ventures 10/20/19 10:01:57 PM
#2941   Gimme some of them 40’s yeeehaaawwwww greendragon420 10/14/19 09:14:51 AM
#2940   Hey "whytestocks" ... Found CBWTF in this article FUNMAN 10/12/19 09:53:22 PM
#2939   Food for thought. “Stocks go up, stocks go greendragon420 10/11/19 05:32:44 AM
#2938   They were saying that on the GTBI$F board Clemdane 10/08/19 09:13:02 PM
#2937   Here is something to think about. Cannada Joe99999 10/08/19 08:30:54 PM
#2936   News: $CBWTF Better Marijuana Stock: Auxly Cannabis vs. whytestocks 10/05/19 08:20:20 AM
#2935   News: $CBWTF Auxly Stock Corrects from Highs: What's whytestocks 10/04/19 01:10:25 PM
#2934   Hope those here took advantage of the dip TheGreatGreenRush 10/04/19 11:22:55 AM
#2933   Nice little dip this morning. Gobbled up some $.54s TheGreatGreenRush 10/02/19 02:13:29 PM
#2932   Stocks go up stocks go down TheGreatGreenRush 10/01/19 10:12:59 AM
#2931   How’s L2 working out for you this morning? greendragon420 10/01/19 09:41:02 AM
#2930   Now $115k in support at $.60 and above TheGreatGreenRush 09/30/19 03:08:29 PM
#2929   Must not have L2. $36k in support at TheGreatGreenRush 09/30/19 02:48:19 PM
#2928   Beep beep beep special price alert. 2 for greendragon420 09/30/19 01:47:02 PM
#2926   I’m gonna get money forever, yup greendragon420 09/28/19 07:28:26 AM
#2924   This will likely hover around 0.6281 all weekend NickDiaz209 09/27/19 06:19:58 PM
#2923   ok vinovista 09/27/19 12:31:38 PM
#2922   I consider .64 and below around .65 until greendragon420 09/27/19 12:16:29 PM
#2921   Yum !..... nowwhat2 09/26/19 12:16:53 PM
#2920   U.S. House of Representatives Passes SAFE Banking Act Diogenes of Sinope 09/25/19 06:37:54 PM
#2919   Auxly Closes C$123 Million Investment and R&D Partnership Diogenes of Sinope 09/25/19 03:12:01 PM
#2918   Auxly Announces Closing of Previously Announced $84 Million Diogenes of Sinope 09/24/19 09:20:58 AM
#2917   I’ve got my shares and I’ve sold gains greendragon420 09/22/19 08:48:24 PM
#2916   Lololol the great green rush has been happening TheGreatGreenRush 09/22/19 06:41:52 PM
#2915   Well 0.6541 technically qualifies I suppose as what vinovista 09/22/19 11:43:46 AM
#2914   Traded .65 within 2 hours of close, I greendragon420 09/22/19 12:50:31 AM
#2913   What pray tell are your parameters for "Hover"? vinovista 09/20/19 07:09:35 PM
#2912   Looking at them short term it looks like greendragon420 09/19/19 05:31:46 PM
#2911   Statistically impossible to be wrong that many times TheGreatGreenRush 09/19/19 04:42:20 PM
#2910   What do your charts say now? vinovista 09/19/19 04:30:00 PM
#2909   Looking at the charts I’m guessing this will greendragon420 09/19/19 10:50:36 AM
#2908   Cannabis Catch-Up: Top Marijuana Stock News for Wednesday, wsstocks 09/18/19 10:25:29 PM
#2907   Auxly and Kindred Announce Canadian Brokerage Agreement Diogenes of Sinope 09/18/19 07:49:30 AM
#2906   50’s are on the horizon. Accumulation time. Load greendragon420 09/17/19 03:02:47 PM
#2905   London Firm Gets Approval to Study Effects of WeedWarrior 09/16/19 03:53:10 PM
#2904   These current U.S. vape issues have not been WeedWarrior 09/13/19 12:21:41 PM
#2903   Auxly has multiple representatives at the Grow Up WeedWarrior 09/12/19 07:57:06 PM
#2900   Auxly up 70% from its low back in TheGreatGreenRush 09/09/19 03:34:18 PM
#2899   Couldn't agree more TheGreatGreenRush 09/09/19 12:53:01 PM
#2898   Well stated! Diogenes of Sinope 09/09/19 12:45:49 PM
#2897   This is a great company and an even mx10001 09/09/19 12:43:14 PM
#2896   Huge difference between bag holding and being patient. TheGreatGreenRush 09/09/19 11:57:00 AM
#2895   Awesome news. Buy hold, buy hold, buy some more. TheGreatGreenRush 09/09/19 11:47:21 AM
#2894   Auxly-Receives-Key-Cannabis-Oil Sales Licences for Dosecann and Kolab Project http://www.globenewswi WeedWarrior 09/09/19 08:08:36 AM
#2893   Auxly Announces Receipt of Key Cannabis Oil Sales Diogenes of Sinope 09/09/19 08:01:40 AM
#2892   Disappointing. I was expecting 3,200%. mx10001 09/08/19 11:41:15 PM
#2891   Auxly-Has-Projected-Sales Growth of 3,056% by Next Year https://fool.com/investing/2019/08/28/4-cann WeedWarrior 09/08/19 05:11:33 PM